Home » A new drug slows the decline of the brain as it begins to forget names and words

A new drug slows the decline of the brain as it begins to forget names and words

by admin

When youth is behind us and the years are running towards the third age, our mental resources are also approaching the finish line. The goal is reached in different conditions, but it is possible to intervene to delay the effects of neuronal aging. Certainly you need commitment and perseverance, but excellent results are obtained with these “3 strategies to strengthen mind and memory with simple and fun exercises”. What is most feared is to slowly slip into a condition of dementia which is usually accompanied by gradual memory loss.

The nerve cells in our brains that we refer to as neurons could be irreparably damaged if Alzheimer’s disease strikes a person. This neurodegenerative disease significantly affects to the point of completely destroying the ability to retain memory and often causes personality changes. Against the progression of this disease, a new drug slows the decline of the brain which begins to forget names and words. Even before reaching the most severe forms of dementia, Alzheimer’s can present itself between the ages of 40 and 50, as well as between the ages of 50 and 60.

A new drug slows the decline of the brain as it begins to forget names and words

Over the years it happens that you cannot remember the name of an acquaintance and a few words do not immediately come to mind. You can try to slow down the rush of time by engaging with simple daily exercises and proper nutrition. For example, “Before the age of 60 this is needed to not lose memory and hearing”. As well as to intervene at the beginning of Alzheimer’s, a new therapy can be used that eliminates the excesses of beta-amyloid protein.

See also  GSE x ACGHK2021 has come to a successful conclusion, and game fans are not hindered by the epidemic panic buying and pre-ordering various game software boutiques-

The latter is in fact responsible for the destruction of neurons so it is against it that we must arm ourselves. The new drug is an ideal monoclonal antibody for patients with incipient forms of dementia and therefore with a mild cognitive decline. This monoclonal antibody is not administered to people who already have the most severe symptoms of Alzheimer’s disease. However, it bodes well for a slower progression of dementia as a reduction in amyloid plaques was recorded during the experimentation.

Deepening

3 teaspoons at lunch to improve memory and mind after 40

(We remind you to carefully read the warnings regarding this article, which can be consulted who”)

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy